‘Real-life experience’: recurrence rate at 3 years with Hexvix® photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC—a prospective controlled study

Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?

(2016) Richard J. Sylvester et al.   EUROPEAN UROLOGY

Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study

(2015) Juan Palou et al.   BJU INTERNATIONAL

A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results

(2015) Tessa Kennedy-Martin et al.   Trials

Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis–assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non–muscle-invasive Bladder Cancer

(2015) Paramananthan Mariappan et al.   UROLOGY

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS)

(2013) J. Alfred Witjes et al.   BJU INTERNATIONAL

Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasi

(2013) Timothy O'Brien et al.   BJU INTERNATIONAL

Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data

(2013) Maximilian Burger et al.   EUROPEAN UROLOGY

Ciblage diagnostique par Hexvix® des tumeurs urothéliales de vessie : résultats après quatre ans d’évaluation prospective monocentrique

(2013) A. Ferré et al.   PROGRES EN UROLOGIE

Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer

(2013) Roman Mayr et al.   Current Urology Reports

Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy

(2012) H. Barton Grossman et al.   JOURNAL OF UROLOGY

A comparison of hexaminolevulinate (Hexvix®) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study

(2012) Alberto Lapini et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across t

(2011) Paramananthan Mariappan et al.   BJU INTERNATIONAL

Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?

(2011) Bogdan Geavlete et al.   BJU INTERNATIONAL

Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in T  a/T1 patients: a randomized two-centre study

(2011) Gregers G. Hermann et al.   BJU INTERNATIONAL

Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer

(2010) Arnulf Stenzl et al.   JOURNAL OF UROLOGY

HAL Blue-light Cystoscopy in High-risk Nonmuscle-invasive Bladder Cancer—Re-TURBT Recurrence Rates in a Prospective, Randomized Study

(2010) Bogdan Geavlete et al.   UROLOGY

WHY DON’T MERCEDES BENZ PUBLISH RANDOMIZED TRIALS?

(2009) Timothy O’Brien et al.   BJU INTERNATIONAL

Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience

(2009) Paramananthan Mariappan et al.   EUROPEAN UROLOGY